CNWDX
Price
$17.32
Change
+$0.03 (+0.17%)
Updated
Jan 21 closing price
Net Assets
377.97M
VEMRX
Price
$92.89
Change
+$0.67 (+0.73%)
Updated
Jan 21 closing price
Net Assets
108.96B
Ad is loading...

CNWDX vs VEMRX

Header iconCNWDX vs VEMRX Comparison
Open Charts CNWDX vs VEMRXBanner chart's image
Calamos Evolving World Growth C
Price$17.32
Change+$0.03 (+0.17%)
VolumeN/A
Net Assets377.97M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$92.89
Change+$0.67 (+0.73%)
VolumeN/A
Net Assets108.96B
CNWDX vs VEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNWDX vs. VEMRX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNWDX is a Hold and VEMRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 109B vs. CNWDX (378M). VEMRX pays higher dividends than CNWDX: VEMRX (3.48) vs CNWDX (0.00). CNWDX was incepted earlier than VEMRX: CNWDX (16 years) vs VEMRX (14 years). CNWDX is a more actively managed with annual turnover of: 137.00 vs. VEMRX (5.00). CNWDX has a lower initial minimum investment than VEMRX: CNWDX (2500) vs VEMRX (100000000). CNWDX (15.24) and VEMRX (14.94) have marching annual gain over last year. CNWDX return over 5 years is better than : 20.95 vs. VEMRX (9.18).
CNWDXVEMRXCNWDX / VEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years14 years-
Gain YTD-0.460-0.118389%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets378M109B0%
Annual Yield % from dividends0.003.48-
Returns for 1 year15.2414.94102%
Returns for 3 years-8.65-4.00216%
Returns for 5 years20.959.18228%
Returns for 10 years35.7426.43135%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLCVX27.330.54
+2.02%
Saratoga Large Capitalization Value I
LMORX39.570.76
+1.96%
Patient Opportunity R
CRMAX11.170.18
+1.64%
CRM Small/Mid Cap Value Inv
TRGIX16.270.15
+0.93%
Nuveen Core Equity Retire
ANDVX10.68N/A
N/A
Virtus NFJ Dividend Value R6